COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ

Cyclooxygenase type-2 (COX-2) is overexpressed in malignant tumours including breast cancers, though the mechanism of upregulation is unclear. This study aimed to determine COX-2 expression in ductal carcinoma in situ (DCIS) in comparison to invasive breast cancer (IBC) and normal breast, and also t...

Descripción completa

Detalles Bibliográficos
Autores principales: Boland, G P, Butt, I S, Prasad, R, Knox, W F, Bundred, N J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Molecular and Cellular Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409574/
https://www.ncbi.nlm.nih.gov/pubmed/14735188
http://dx.doi.org/10.1038/sj.bjc.6601534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409574/
https://www.ncbi.nlm.nih.gov/pubmed/14735188
http://dx.doi.org/10.1038/sj.bjc.6601534

Ejemplares similares